Evidence map›Paper›PMID 26260078›Full record

ArticleSchizophrenia research2015

Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.

Chijioke N Egbujo, Duncan Sinclair, Karin E Borgmann-Winter, Steven E Arnold, Bruce I Turetsky, Chang-Gyu Hahn

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Disrupted Olfactory Integration in Schizophrenia: Functional Connectivity Study.The international journal of neuropsychopharmacology · 2017
    Article
  9. Article
  10. Review
  11. Review
  12. SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond.Journal of neural transmission (Vienna, Austria : 1996) · 2016
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chijioke N EgbujoDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Duncan SinclairDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Karin E Borgmann-WinterDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA; Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Steven E ArnoldDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Bruce I TuretskyDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Chang-Gyu HahnDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: hahnc@mail.med.upenn.edu.
University of Pennsylvania · USChildren's Hospital of Philadelphia · US

Funding

NMDA Receptor Hypofunction in the Amygdala of Schizophrenia PatientsP50MH096891 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 2012 to 2016
$10.6M
Olfactory Evoked Potentials and Developmental Neuropathology in SchizophreniaR01MH059852 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI HAHN, CHANG-GYU, TURETSKY, BRUCE I · 1999 to 2015
$6.6M
TRAINING PROGRAM IN NEUROPSYCHOPHARMACOLOGY-PREDOCTORALT32MH014654 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 1985 to 2021
$5.0M
Institutional Clinical and Translational Science AwardKL2TR000139 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$3.9M
Src mediates molecular alterations leading to NMDAR hypofunction in schizophreniaR01MH075916 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BORGMANN-WINTER, KARIN, HAHN, CHANG-GYU · 2006 to 2019
$3.3M
Lithium responsivenessR01MH080193 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI HAHN, CHANG-GYU · 2008 to 2012
$2.7M
Neuroprotective/Neurodevelopmental Effects-Antipsychotics in Adolescent PsychosesK23MH079498 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI BORGMANN-WINTER, KARIN · 2010 to 2014
$819k
NCATS NIH HHS 5KL2TR000139NIMH NIH HHS 5T32MH014654NIMH NIH HHS K23 MH079498NIMH NIH HHS K23MH079498NIMH NIH HHS P50 MH096891NIMH NIH HHS P50-MH-096891NIMH NIH HHS R01 MH059852NIMH NIH HHS R01-MH-059852NIMH NIH HHS R01 MH075916NIMH NIH HHS R01-MH-080193NIMH NIH HHS T32 MH014654
6 · The paper itself

Abstract

Multiple lines of evidence suggest altered synaptic plasticity/connectivity as a pathophysiologic mechanism for various symptom domains of schizophrenia. Olfactory dysfunction, an endophenotype of schizophrenia, reflects altered activity of the olfactory circuitry, which conveys signals from olfactory receptor neurons to the olfactory cortex via synaptic connections in the glomeruli of the olfactory bulb. The olfactory system begins with intranasal olfactory receptor neuron axons synapsing with mitral and tufted cells in the glomeruli of the olfactory bulb, which then convey signals directly to the olfactory cortex. We hypothesized that olfactory dysfunction in schizophrenia is associated with dysregulation of synaptic efficacy in the glomeruli of the olfactory bulb. To test this, we employed semi-quantitative immunohistochemistry to examine the olfactory bulbs of 13 postmortem samples from schizophrenia and their matched control pairs for glomerular expression of 5 pre- and postsynaptic proteins that are involved in the integrity and function of synapses. In the glomeruli of schizophrenia cases compared to their matched controls, we found significant decreases in three presynaptic proteins which play crucial roles in vesicular glutamate transport - synapsin IIa (-18.05%, p=0.019), synaptophysin (-24.08% p=0.0016) and SNAP-25 (-23.9%, p=0.046). Two postsynaptic proteins important for spine formation and glutamatergic signaling were also decreased-spinophilin (-17.40%, p=0.042) and PSD-95 (-34.06%, p=0.015). These findings provide molecular evidence for decreased efficacy of synapses within the olfactory bulb, which may represent a synaptic mechanism underlying olfactory dysfunction in schizophrenia.

Indexed as

AdultAgedAged, 80 and overAntipsychotic AgentsDisks Large Homolog 4 ProteinFemaleHumansImmunohistochemistryIntracellular Signaling Peptides and ProteinsMaleMembrane ProteinsMicrofilament ProteinsNerve Tissue ProteinsNeurabinsOlfactory BulbSchizophreniaAntipsychotic AgentsDisks Large Homolog 4 ProteinDLG4 protein, humanIntracellular Signaling Peptides and ProteinsMembrane ProteinsMicrofilament ProteinsNerve Tissue ProteinsNeurabinsSNAP25 protein, humanSYN2 protein, humanSynapsinsSynaptophysinSynaptosomal-Associated Protein 25SYP protein, humanOlfactory bulbPSD-95SchizophreniaSNAP-25SynapseSynaptophysin

Identifiers

PMID26260078
PMCPMC5119750
OpenAlexW1854509816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.